Table 6.
Location of forefoot pathology in the RA participants(n (%)) at baseline and twelve months.
| Pathology | Lateral dominance |
Medial dominance |
Equally distributed | No pathology | |
|---|---|---|---|---|---|
| Baseline | |||||
| SynHy | Left | 37 (33%) | 19 (17%) | 15 (13%) | 43 (38%) |
| Right | 31 (27%) | 25 (22%) | 10 (9%) | 48 (42%) | |
| Erosion | Left | 94 (83%) | 1 (1%) | 6 (5%) | 11 (10%) |
| Right | 88 (77%) | 2 (2%) | 6 (5%) | 18 (16%) | |
| BurHy | Left | 58 (51%) | 18 (16%) | 20 (18%) | 18 (16%) |
| Right | 56 (49%) | 13 (11%) | 27 (24%) | 18 (16%) | |
| Twelve Months | |||||
| SynHy | Left | 15 (13%) | 34 (30%) | 7 (6%) | 58 (51%) |
| Right | 19 (17%) | 26 (23%) | 14 (12%) | 55 (48%) | |
| Erosion | Left | 96 (84%) | 1 (1%) | 11 (10%) | 5 (4%) |
| Right | 89 (78%) | 1 (1%) | 14 (12%) | 10 (9%) | |
| BurHy | Left | 61 (54%) | 7(6%) | 32 (28%) | 14 (12%) |
| Right | 63 (55%) | 14 (12%) | 22 (19%) | 15 (13%) | |
Legend: SynHy: MTP joint synovial hypertrophy; BurHy: Forefoot bursal hypertrophy.